Status: Not funded
Effective date: 1 April 2026
Next review date: 1 April 2031
Essex ICB does not routine commission Photodynamic Therapy (PDT) for age-related Macular Degeneration (AMD).
NICE NG82 replaced previous PDT guidance and does not support PDT for routine AMD care.
This service/procedure has been assessed as a Low Clinical Priority by MSE ICB and will not be funded unless there are exceptional clinical circumstances.
Individual funding requests should only be made where the patient demonstrates clinical exceptionality.
Further information on applying for funding in exceptional clinical circumstances can be found on the ICB website.